Jupiter Topco LLC Makes New Investment in Integer Holdings Corporation $ITGR

Jupiter Topco LLC bought a new position in shares of Integer Holdings Corporation (NYSE:ITGR) during the 2nd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor bought 76,688 shares of the medical equipment provider’s stock, valued at approximately $7,168,000. Jupiter Topco LLC owned approximately 0.23% of Integer as of its most recent SEC filing.

A number of other institutional investors have also recently modified their holdings of ITGR. Hsbc Holdings PLC purchased a new position in shares of Integer in the 2nd quarter valued at about $3,292,000. Palisade Capital Management LP purchased a new position in Integer during the second quarter worth approximately $9,642,000. Legal & General Group Plc purchased a new position in Integer during the second quarter worth approximately $7,170,000. The Manufacturers Life Insurance Company acquired a new stake in Integer in the second quarter valued at approximately $50,925,000. Finally, Cibc World Market Inc. acquired a new stake in Integer in the second quarter valued at approximately $30,381,000. 99.29% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of analysts have recently commented on the company. Piper Sandler cut Integer from an “overweight” rating to a “hold” rating and set a $127.00 price objective for the company. in a research report on Monday, August 3rd. Benchmark cut shares of Integer from a “buy” rating to a “hold” rating in a research note on Thursday, August 13th. Truist Financial lowered shares of Integer from a “buy” rating to a “hold” rating and boosted their price target for the stock from $110.00 to $127.00 in a report on Monday, August 3rd. Freedom Capital cut shares of Integer from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, August 4th. Finally, Raymond James Financial cut shares of Integer from a “moderate buy” rating to a “hold” rating in a research report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating and thirteen have given a Hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $109.86.

Integer Stock Performance

NYSE ITGR opened at $125.30 on Monday. The company has a market cap of $4.26 billion, a PE ratio of 34.24, a price-to-earnings-growth ratio of 2.96 and a beta of 0.61. The stock’s 50 day simple moving average is $107.58 and its 200-day simple moving average is $94.54. Integer Holdings Corporation has a 1-year low of $62.00 and a 1-year high of $126.14. The company has a debt-to-equity ratio of 0.75, a current ratio of 3.73 and a quick ratio of 2.41.

Integer (NYSE:ITGR) last issued its quarterly earnings results on Monday, August 3rd. The medical equipment provider reported $1.60 EPS for the quarter, topping the consensus estimate of $1.38 by $0.22. Integer had a return on equity of 12.79% and a net margin of 6.97%.The firm had revenue of $464.11 million during the quarter, compared to analysts’ expectations of $451.07 million. During the same period in the previous year, the business earned $1.55 earnings per share. The firm’s revenue for the quarter was down 2.6% on a year-over-year basis. As a group, equities research analysts anticipate that Integer Holdings Corporation will post 6.09 EPS for the current fiscal year.

About Integer

Integer Holdings Corporation (NYSE: ITGR) is a global provider of outsourced medical device design, development and manufacturing solutions. The company partners with leading medical technology firms to deliver complex components, subsystems and finished devices across a range of therapeutic areas. Its services encompass concept and product design, precision machining, microelectronic assembly, terminal sterilization and regulatory support, enabling customers to accelerate time to market and optimize product performance.

Integer’s product portfolio is organized into two core segments: Advanced Delivery and MedTech.